Comparative study of occurance of dry eye between postmenopausal woman taking hormonal replacement therapy and without hormonal replacement therapy

---

Original Article

Author Details : Prasanta Kumar Nanda, Sabita Mohanta*, Purnima Nanda

Volume : 5, Issue : 4, Year : 2019

Article Page : 217-221

https://doi.org/10.18231/j.ijooo.2019.050

Suggest article by email

Get Permission

---

Abstract

Aim: To compare occurance of dry eye between postmenopausal woman taking hormonal replacement
therapy and without hormonal replacement therapy.
Materials and Methods: A comparative study was done to determine the occurance of dry eye in those
women with hormonal replacement therapy and control subject. Study was done in tertiary eye care hospital
with patients of postmenopausal women taking hormonal replacement therapy and postmenopausal women
who were not taking hormone replacement therapy from Jan 2019-June 2019. Schirmer’s test, tear film
breakup time and Rose Bengal staining were performed on all participants.
Results: 40 women were examined. Group A-15 were taking hormone both estrogen and progesterone.
Group B -25 patients who are not taking hormone replacement therapy. Dry eye was found in women who
are not taking hormone replacement therapy.
Conclusion: Dry eye was more common in post menopausal women who are not taking hormonal therapy
as compared to post menopausal women taking hormone replacement therapy in our study. It shows female
hormone is protective against dry eye.

Keywords: Postmenopausal women, Hormone replacement therapy.

How to cite : Nanda P K, Mohanta S , Nanda P, Comparative study of occurance of dry eye between postmenopausal woman taking hormonal replacement therapy and without hormonal replacement therapy. IP Int J Ocul Oncol Oculoplasty 2019;5(4):217-221

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.